167 related articles for article (PubMed ID: 38245323)
1. Conventional management and current guidelines for painful diabetic neuropathy.
Tesfaye S; Kempler P
Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110765. PubMed ID: 38245323
[TBL] [Abstract][Full Text] [Related]
2. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
[TBL] [Abstract][Full Text] [Related]
3. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Carlos F; Espejel L; Novick D; López R; Flores D
Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
[TBL] [Abstract][Full Text] [Related]
5. An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy.
Qureshi Z; Ali MN; Khalid M
J Diabetes Res; 2022; 2022():9989272. PubMed ID: 35127954
[TBL] [Abstract][Full Text] [Related]
6. Diabetic peripheral neuropathy essentials: a narrative review.
Chang MC; Yang S
Ann Palliat Med; 2023 Mar; 12(2):390-398. PubMed ID: 36786097
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review.
Hossain SM; Hussain SM; Ekram AR
Clin J Pain; 2016 Nov; 32(11):1005-1010. PubMed ID: 26710221
[TBL] [Abstract][Full Text] [Related]
8. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
Jang HN; Oh TJ
Diabetes Metab J; 2023 Nov; 47(6):743-756. PubMed ID: 37670573
[TBL] [Abstract][Full Text] [Related]
10. Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.
D'Souza RS; Barman R; Joseph A; Abd-Elsayed A
Curr Pain Headache Rep; 2022 Aug; 26(8):583-594. PubMed ID: 35716275
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
12. Treating Painful Diabetic Peripheral Neuropathy: An Update.
Snyder MJ; Gibbs LM; Lindsay TJ
Am Fam Physician; 2016 Aug; 94(3):227-34. PubMed ID: 27479625
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based interventional pain medicine according to clinical diagnoses. 18. Painful diabetic polyneuropathy.
Pluijms W; Huygen F; Cheng J; Mekhail N; van Kleef M; Van Zundert J; van Dongen R
Pain Pract; 2011; 11(2):191-8. PubMed ID: 21199315
[TBL] [Abstract][Full Text] [Related]
14. Where does spinal cord stimulation fit into the international guidelines for refractory painful diabetic neuropathy? a consensus statement.
Boulton AJM; Jensen TS; Luecke T; Petersen EA; Pop-Busui R; Taylor RS; Tesfaye S; Vileikyte L; Ziegler D
Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110763. PubMed ID: 38245326
[TBL] [Abstract][Full Text] [Related]
15. A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy.
Khasbage S; Shukla R; Sharma P; Singh S
J Diabetes; 2021 Jul; 13(7):532-541. PubMed ID: 33340245
[TBL] [Abstract][Full Text] [Related]
16. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
Bellows BK; Nelson RE; Oderda GM; LaFleur J
Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy for painful diabetic neuropathy is safe and effective.
Saul H; Deeney B; Imison C; Tesfaye S
BMJ; 2023 Apr; 381():866. PubMed ID: 37085164
[TBL] [Abstract][Full Text] [Related]
18. Current Strategies for the Management of Painful Diabetic Neuropathy.
Staudt MD; Prabhala T; Sheldon BL; Quaranta N; Zakher M; Bhullar R; Pilitsis JG; Argoff CE
J Diabetes Sci Technol; 2022 Mar; 16(2):341-352. PubMed ID: 32856490
[TBL] [Abstract][Full Text] [Related]
19. Management of diabetic neuropathy.
Cernea S; Raz I
Metabolism; 2021 Oct; 123():154867. PubMed ID: 34411554
[TBL] [Abstract][Full Text] [Related]
20. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.
Zin CS; Nissen LM; Smith MT; O'Callaghan JP; Moore BJ
CNS Drugs; 2008; 22(5):417-42. PubMed ID: 18399710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
